Scynexis Stock EBITDA

SCYX Stock

USD 1.20 0.01 0.84%

Scynexis fundamentals help investors to digest information that contributes to Scynexis' financial success or failures. It also enables traders to predict the movement of Scynexis Stock. The fundamental analysis module provides a way to measure Scynexis' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Scynexis stock.

		Last Reported	Projected for Next Year
	EBITDA	73.5 M	77.2 M

EBITDA is likely to rise to about 77.2 M in 2024.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Scynexis Company EBITDA Analysis

Scynexis' EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

EBITDA

Revenue

-

Basic Expenses

More About EBITDA | All Equity Analysis

Current Scynexis EBITDA

73.48 M

Most of Scynexis' fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Scynexis is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Scynexis EBITDA Driver Correlations

Understanding the fundamental principles of building solid financial models for Scynexis is extremely important. It helps to project a fair market value of Scynexis Stock properly, considering its historical fundamentals such as EBITDA. Since Scynexis' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Scynexis' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Scynexis' interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Property Plant Equipment	Common Stock	Net Tangible Assets	Capital Surpluse	Deferred Long Term Liab	Long Term Debt Total	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.7	0.48	-0.7	-0.88	0.82	0.45	0.42	0.72	0.99	-0.69	-0.69	0.45	0.07	0.95	-0.77	0.85	-0.75	0.76	0.9	-0.38
Total Stockholder Equity	0.7		0.11	-0.61	-0.6	0.43	-0.07	0.66	0.11	0.71	-0.48	-0.73	0.36	-0.01	0.55	-0.66	0.38	-0.43	0.61	0.58	-0.23
Current Deferred Revenue	0.48	0.11		-0.56	-0.51	0.61	0.16	0.07	0.59	0.49	-0.52	-0.21	0.61	-0.6	0.51	-0.45	0.36	-0.56	-0.03	0.4	0.19
Net Debt	-0.7	-0.61	-0.56		0.5	-0.41	0.02	-0.03	-0.35	-0.76	0.42	0.48	-0.28	0.06	-0.49	0.54	-0.45	0.36	-0.29	-0.55	0.24
Retained Earnings	-0.88	-0.6	-0.51	0.5		-0.87	-0.64	-0.49	-0.8	-0.88	0.77	0.72	-0.58	0.1	-0.93	0.82	-0.74	0.84	-0.62	-0.83	0.29
Accounts Payable	0.82	0.43	0.61	-0.41	-0.87		0.55	0.36	0.76	0.79	-0.75	-0.64	0.74	-0.24	0.9	-0.75	0.64	-0.89	0.61	0.79	0.02
Long Term Debt	0.45	-0.07	0.16	0.02	-0.64	0.55		0.05	0.8	0.44	-0.44	-0.28	0.23	0.19	0.6	-0.39	0.57	-0.5	0.37	0.51	-0.31
Net Receivables	0.42	0.66	0.07	-0.03	-0.49	0.36	0.05		0.19	0.34	-0.39	-0.3	0.25	-0.13	0.46	-0.33	0.37	-0.35	0.59	0.52	-0.17
Total Liab	0.72	0.11	0.59	-0.35	-0.8	0.76	0.8	0.19		0.69	-0.58	-0.27	0.3	-0.01	0.82	-0.48	0.82	-0.67	0.52	0.8	-0.39
Total Current Assets	0.99	0.71	0.49	-0.76	-0.88	0.79	0.44	0.34	0.69		-0.7	-0.73	0.47	0.03	0.91	-0.82	0.79	-0.75	0.68	0.85	-0.37
Short Term Debt	-0.69	-0.48	-0.52	0.42	0.77	-0.75	-0.44	-0.39	-0.58	-0.7		0.47	-0.63	0.36	-0.72	0.62	-0.52	0.86	-0.45	-0.66	0.09
Property Plant Equipment	-0.69	-0.73	-0.21	0.48	0.72	-0.64	-0.28	-0.3	-0.27	-0.73	0.47		-0.67	0.07	-0.65	0.93	-0.28	0.65	-0.4	-0.44	-0.03
Common Stock	0.45	0.36	0.61	-0.28	-0.58	0.74	0.23	0.25	0.3	0.47	-0.63	-0.67		-0.54	0.53	-0.72	0.09	-0.71	0.11	0.29	0.56
Net Tangible Assets	0.07	-0.01	-0.6	0.06	0.1	-0.24	0.19	-0.13	-0.01	0.03	0.36	0.07	-0.54		0.03	0.24	0.33	0.37	0.39	0.12	-0.47
Capital Surpluse	0.95	0.55	0.51	-0.49	-0.93	0.9	0.6	0.46	0.82	0.91	-0.72	-0.65	0.53	0.03		-0.76	0.87	-0.83	0.75	0.89	-0.3
Deferred Long Term Liab	-0.77	-0.66	-0.45	0.54	0.82	-0.75	-0.39	-0.33	-0.48	-0.82	0.62	0.93	-0.72	0.24	-0.76		-0.41	0.82	-0.39	-0.56	0.07
Long Term Debt Total	0.85	0.38	0.36	-0.45	-0.74	0.64	0.57	0.37	0.82	0.79	-0.52	-0.28	0.09	0.33	0.87	-0.41		-0.54	0.78	0.89	-0.6
Short Long Term Debt	-0.75	-0.43	-0.56	0.36	0.84	-0.89	-0.5	-0.35	-0.67	-0.75	0.86	0.65	-0.71	0.37	-0.83	0.82	-0.54		-0.48	-0.68	0.08
Net Invested Capital	0.76	0.61	-0.03	-0.29	-0.62	0.61	0.37	0.59	0.52	0.68	-0.45	-0.4	0.11	0.39	0.75	-0.39	0.78	-0.48		0.88	-0.49
Net Working Capital	0.9	0.58	0.4	-0.55	-0.83	0.79	0.51	0.52	0.8	0.85	-0.66	-0.44	0.29	0.12	0.89	-0.56	0.89	-0.68	0.88		-0.5
Capital Stock	-0.38	-0.23	0.19	0.24	0.29	0.02	-0.31	-0.17	-0.39	-0.37	0.09	-0.03	0.56	-0.47	-0.3	0.07	-0.6	0.08	-0.49	-0.5

Click cells to compare fundamentals

In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.

Competition

Predict Scynexis

Ebitda Over Time

Scynexis Ebitda

Ebitda

77.15 Million

At this time, Scynexis' EBITDA is fairly stable compared to the past year.

According to the company disclosure, Scynexis reported earnings before interest,tax, depreciation and amortization of 73.48 M. This is 91.63% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The ebitda for all United States stocks is 98.12% higher than that of the company.

Scynexis EBITDA Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Scynexis' direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Scynexis could also be used in its relative valuation, which is a method of valuing Scynexis by comparing valuation metrics of similar companies.

Scynexis is currently under evaluation in ebitda category among its peers.

Scynexis Current Valuation Drivers

We derive many important indicators used in calculating different scores of Scynexis from analyzing Scynexis' financial statements. These drivers represent accounts that assess Scynexis' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Scynexis' important valuation drivers and their relationship over time.

	2019	2020	2021	2022	2023	2024 (projected)
Market Cap	51.0M	82.0M	160.9M	66.5M	106.7M	59.5M
Enterprise Value	24.0M	8.8M	100.1M	69.3M	87.7M	92.1M

Scynexis Institutional Holders

Institutional Holdings refers to the ownership stake in Scynexis that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Scynexis' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Scynexis' value.

		Shares
Renaissance Technologies Corp	2024-09-30	145.7 K
State Street Corp	2024-06-30	107.3 K
Wealth Effects Llc	2024-09-30	102 K
Northern Trust Corp	2024-09-30	101.1 K
Empowered Funds, Llc	2024-06-30	95.3 K
Nierenberg Investment Management Co	2024-09-30	75.6 K
Lpl Financial Corp	2024-09-30	75.5 K
Squarepoint Ops Llc	2024-06-30	47.8 K
Morgan Stanley - Brokerage Accounts	2024-06-30	39.6 K
Federated Hermes Inc	2024-09-30	3.6 M
Kingdon Capital Management Llc	2024-06-30	2.2 M

Scynexis Fundamentals

	Return On Equity	-0.48
	Return On Asset	-0.27
	Operating Margin	(15.64) %
	Current Valuation	(7.4 M)
	Shares Outstanding	37.94 M
	Shares Owned By Insiders	1.10 %
	Shares Owned By Institutions	44.38 %
	Number Of Shares Shorted	866.97 K
	Price To Earning	(1.90) X
	Price To Book	0.78 X
	Price To Sales	5.32 X
	Revenue	140.14 M
	Gross Profit	12.85 M
	EBITDA	73.48 M
	Net Income	67.04 M
	Cash And Equivalents	96.09 M
	Cash Per Share	2.94 X
	Total Debt	15.08 M
	Debt To Equity	2.80 %
	Current Ratio	7.26 X
	Book Value Per Share	1.54 X
	Cash Flow From Operations	60.16 M
	Short Ratio	6.39 X
	Earnings Per Share	(0.76) X
	Target Price	6.67
	Number Of Employees	29
	Beta	1.5
	Market Capitalization	45.53 M
	Total Asset	128.41 M
	Retained Earnings	(355.25 M)
	Working Capital	85.81 M
	Current Asset	48.44 M
	Current Liabilities	6.66 M
	Net Asset	128.41 M

About Scynexis Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Scynexis's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Scynexis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Scynexis based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Scynexis Stock Analysis

When running Scynexis' price analysis, check to measure Scynexis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scynexis is operating at the current time. Most of Scynexis' value examination focuses on studying past and present price action to predict the probability of Scynexis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scynexis' price. Additionally, you may evaluate how the addition of Scynexis to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC